Page 5 - இந்தியா மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Welcome To IANS Live - TopStory - RDIF awaiting SEC recommendation for Sputnik approval in India

Welcome To IANS Live - TopStory - RDIF awaiting SEC recommendation for Sputnik approval in India
ianslive.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ianslive.in Daily Mail and Mail on Sunday newspapers.

New delhiIndia central drugs standard control organisationNews serviceIndia privateExpert committeeRussian direct investment fundSubject expert committeeCentral drugs standard control organisationAll rightsபுதியது டெல்ஹிஇந்தியா மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந்செய்தி சேவைஇந்தியா ப்ரைவேட்நிபுணர் குழுரஷ்ய நேரடி முதலீடு நிதிபொருள் நிபுணர் குழு

Covid-19 vaccine: India govt s expert committee recommends emergency use approval for Sputnik V

Covid-19 vaccine: India govt s expert committee recommends emergency use approval for Sputnik V
thedailystar.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thedailystar.net Daily Mail and Mail on Sunday newspapers.

Oxford astrazenecaIndian council of medical researchRussian direct investment fundDr reddy laboratoryVirchow biotech private limited of indiaIndia central drugs standard control organizationStelis biopharma pvt ltdExpert committeeSerum institute of indiaSubject expert committeeCentral drugs standard control organizationDrugs controller generalIndian councilBharat biotechSerum instituteVirchow biotech private limited

Welcome To IANS Live - NATION - RDIF awaiting SEC recommendation for Sputnik approval in India

Welcome To IANS Live - NATION - RDIF awaiting SEC recommendation for Sputnik approval in India
ianslive.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ianslive.in Daily Mail and Mail on Sunday newspapers.

RDIF awaiting SEC recommendation for Sputnik approval in India

RDIF awaiting SEC recommendation for Sputnik approval in India
prokerala.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prokerala.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomNew delhiRepublic ofSanjeev sharmaIndia central drugs standard control organisationCentral drugs standard control organizationExpert committeeRussian direct investment fundSubject expert committeeCentral drugs standard control organisationUnited kingdom basedLatin americaMiddle eastNorth africaஒன்றுபட்டது மாநிலங்களில்

Johnson & Johnson In Talks With Indian Government to Trial Single-Dose Vaccine

Johnson & Johnson In Talks With Indian Government to Trial Single-Dose Vaccine 10/04/2021 Vials and syringe in front of Johnson & Johnson logo. Photo: Reuters/Dado Ruvic/Illustration/File Photo Bengaluru: Johnson & Johnson is in talks with India’s government to begin a clinical trial of its single-dose COVID-19 vaccine in the country, the company said on Friday. The US drugs and healthcare giant’s vaccine is currently approved for use in the United States, the European Union and other nations including Thailand and South Africa. The news comes as some parts of India face a shortage of vaccine supplies just as the country of 1.3 billion battles a second wave of COVID-19 infections. India’s government, however, has said there is no shortage of shots.

South africaUnited statesIndia central drugs standard control organisationE ltdEuropean unionCadila healthcare ltdOxford universityIndian expressCentral drugs standard control organisationBiologicale ltdCadila healthcareஒன்றுபட்டது மாநிலங்களில்இந்தியா மைய மருந்துகள் தரநிலை கட்டுப்பாடு ஆர்கநைஸேஶந்ஏ லிமிடெட்ஐரோப்பிய தொழிற்சங்கம்காடிலா சுகாதாரம் லிமிடெட்